IBDEI01R ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3843,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
 ;;^UTILITY(U,$J,358.3,3843,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,3843,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,3844,0)
 ;;=N06.0^^33^277^39
 ;;^UTILITY(U,$J,358.3,3844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3844,1,3,0)
 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,3844,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,3844,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,3845,0)
 ;;=N06.1^^33^277^38
 ;;^UTILITY(U,$J,358.3,3845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3845,1,3,0)
 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,3845,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,3845,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,3846,0)
 ;;=N06.2^^33^277^35
 ;;^UTILITY(U,$J,358.3,3846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3846,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,3846,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,3846,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,3847,0)
 ;;=N06.3^^33^277^36
 ;;^UTILITY(U,$J,358.3,3847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3847,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,3847,1,4,0)
 ;;=4^N06.3
 ;;^UTILITY(U,$J,358.3,3847,2)
 ;;=^5015552
 ;;^UTILITY(U,$J,358.3,3848,0)
 ;;=N06.4^^33^277^34
 ;;^UTILITY(U,$J,358.3,3848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3848,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,3848,1,4,0)
 ;;=4^N06.4
 ;;^UTILITY(U,$J,358.3,3848,2)
 ;;=^5015553
 ;;^UTILITY(U,$J,358.3,3849,0)
 ;;=N06.5^^33^277^37
 ;;^UTILITY(U,$J,358.3,3849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3849,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
 ;;^UTILITY(U,$J,358.3,3849,1,4,0)
 ;;=4^N06.5
 ;;^UTILITY(U,$J,358.3,3849,2)
 ;;=^5015554
 ;;^UTILITY(U,$J,358.3,3850,0)
 ;;=N06.6^^33^277^32
 ;;^UTILITY(U,$J,358.3,3850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3850,1,3,0)
 ;;=3^Isolated proteinuria w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,3850,1,4,0)
 ;;=4^N06.6
 ;;^UTILITY(U,$J,358.3,3850,2)
 ;;=^5015555
 ;;^UTILITY(U,$J,358.3,3851,0)
 ;;=N06.7^^33^277^33
 ;;^UTILITY(U,$J,358.3,3851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3851,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,3851,1,4,0)
 ;;=4^N06.7
 ;;^UTILITY(U,$J,358.3,3851,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,3852,0)
 ;;=N06.8^^33^277^40
 ;;^UTILITY(U,$J,358.3,3852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3852,1,3,0)
 ;;=3^Isolated proteinuria w/ other morphologic lesion
 ;;^UTILITY(U,$J,358.3,3852,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,3852,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,3853,0)
 ;;=N06.9^^33^277^41
 ;;^UTILITY(U,$J,358.3,3853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3853,1,3,0)
 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
 ;;^UTILITY(U,$J,358.3,3853,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,3853,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,3854,0)
 ;;=N07.0^^33^277^29
 ;;^UTILITY(U,$J,358.3,3854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3854,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,3854,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,3854,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,3855,0)
 ;;=N07.1^^33^277^28
 ;;^UTILITY(U,$J,358.3,3855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3855,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,3855,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,3855,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,3856,0)
 ;;=N07.2^^33^277^24
 ;;^UTILITY(U,$J,358.3,3856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3856,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,3856,1,4,0)
 ;;=4^N07.2
 ;;^UTILITY(U,$J,358.3,3856,2)
 ;;=^5015561
 ;;^UTILITY(U,$J,358.3,3857,0)
 ;;=N07.3^^33^277^25
 ;;^UTILITY(U,$J,358.3,3857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3857,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,3857,1,4,0)
 ;;=4^N07.3
 ;;^UTILITY(U,$J,358.3,3857,2)
 ;;=^5015562
 ;;^UTILITY(U,$J,358.3,3858,0)
 ;;=N07.4^^33^277^23
 ;;^UTILITY(U,$J,358.3,3858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3858,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,3858,1,4,0)
 ;;=4^N07.4
 ;;^UTILITY(U,$J,358.3,3858,2)
 ;;=^5015563
 ;;^UTILITY(U,$J,358.3,3859,0)
 ;;=N07.5^^33^277^26
 ;;^UTILITY(U,$J,358.3,3859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3859,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,3859,1,4,0)
 ;;=4^N07.5
 ;;^UTILITY(U,$J,358.3,3859,2)
 ;;=^5015564
 ;;^UTILITY(U,$J,358.3,3860,0)
 ;;=N07.6^^33^277^22
 ;;^UTILITY(U,$J,358.3,3860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3860,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,3860,1,4,0)
 ;;=4^N07.6
 ;;^UTILITY(U,$J,358.3,3860,2)
 ;;=^5015565
 ;;^UTILITY(U,$J,358.3,3861,0)
 ;;=N07.7^^33^277^27
 ;;^UTILITY(U,$J,358.3,3861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3861,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,3861,1,4,0)
 ;;=4^N07.7
 ;;^UTILITY(U,$J,358.3,3861,2)
 ;;=^5015566
 ;;^UTILITY(U,$J,358.3,3862,0)
 ;;=N07.8^^33^277^30
 ;;^UTILITY(U,$J,358.3,3862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3862,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ oth morphologic lesions
 ;;^UTILITY(U,$J,358.3,3862,1,4,0)
 ;;=4^N07.8
 ;;^UTILITY(U,$J,358.3,3862,2)
 ;;=^5015567
 ;;^UTILITY(U,$J,358.3,3863,0)
 ;;=N07.9^^33^277^31
 ;;^UTILITY(U,$J,358.3,3863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3863,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ unsp morphologic lesions
 ;;^UTILITY(U,$J,358.3,3863,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,3863,2)
 ;;=^5015568
 ;;^UTILITY(U,$J,358.3,3864,0)
 ;;=N08.^^33^277^21
 ;;^UTILITY(U,$J,358.3,3864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3864,1,3,0)
 ;;=3^Glomerular disorders in diseases classified elsewhere
 ;;^UTILITY(U,$J,358.3,3864,1,4,0)
 ;;=4^N08.
 ;;^UTILITY(U,$J,358.3,3864,2)
 ;;=^5015569
 ;;^UTILITY(U,$J,358.3,3865,0)
 ;;=C90.00^^33^278^10
 ;;^UTILITY(U,$J,358.3,3865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3865,1,3,0)
 ;;=3^Multiple myeloma not having achieved remission
 ;;^UTILITY(U,$J,358.3,3865,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,3865,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,3866,0)
 ;;=C90.01^^33^278^9
 ;;^UTILITY(U,$J,358.3,3866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3866,1,3,0)
 ;;=3^Multiple myeloma in remission
 ;;^UTILITY(U,$J,358.3,3866,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,3866,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,3867,0)
 ;;=C90.02^^33^278^8
 ;;^UTILITY(U,$J,358.3,3867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3867,1,3,0)
 ;;=3^Multiple myeloma in relapse
 ;;^UTILITY(U,$J,358.3,3867,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,3867,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,3868,0)
 ;;=E11.29^^33^278^21
 ;;^UTILITY(U,$J,358.3,3868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3868,1,3,0)
 ;;=3^Type 2 DM w/ Oth Diabetic Kidney Complications
 ;;^UTILITY(U,$J,358.3,3868,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,3868,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,3869,0)
 ;;=E11.21^^33^278^20
 ;;^UTILITY(U,$J,358.3,3869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3869,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic nephropathy
 ;;^UTILITY(U,$J,358.3,3869,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,3869,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,3870,0)
 ;;=E11.22^^33^278^19
 ;;^UTILITY(U,$J,358.3,3870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3870,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,3870,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,3870,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,3871,0)
 ;;=E10.29^^33^278^18
 ;;^UTILITY(U,$J,358.3,3871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3871,1,3,0)
 ;;=3^Type 1 DM w/ Oth Diabetic Kidney Complications
 ;;^UTILITY(U,$J,358.3,3871,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,3871,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,3872,0)
 ;;=E10.21^^33^278^17
 ;;^UTILITY(U,$J,358.3,3872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3872,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,3872,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,3872,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,3873,0)
 ;;=E10.22^^33^278^16
 ;;^UTILITY(U,$J,358.3,3873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3873,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,3873,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,3873,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,3874,0)
 ;;=D59.3^^33^278^3
 ;;^UTILITY(U,$J,358.3,3874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3874,1,3,0)
 ;;=3^Hemolytic-uremic syndrome
 ;;^UTILITY(U,$J,358.3,3874,1,4,0)
 ;;=4^D59.3
 ;;^UTILITY(U,$J,358.3,3874,2)
 ;;=^55823
 ;;^UTILITY(U,$J,358.3,3875,0)
 ;;=D69.0^^33^278^4
 ;;^UTILITY(U,$J,358.3,3875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3875,1,3,0)
 ;;=3^Henoch-Schoeniein Purpura
 ;;^UTILITY(U,$J,358.3,3875,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,3875,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,3876,0)
 ;;=M30.0^^33^278^12
 ;;^UTILITY(U,$J,358.3,3876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3876,1,3,0)
 ;;=3^Polyarteritis nodosa
 ;;^UTILITY(U,$J,358.3,3876,1,4,0)
 ;;=4^M30.0
 ;;^UTILITY(U,$J,358.3,3876,2)
 ;;=^5011738
 ;;^UTILITY(U,$J,358.3,3877,0)
 ;;=M31.0^^33^278^5
 ;;^UTILITY(U,$J,358.3,3877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3877,1,3,0)
 ;;=3^Hypersensitivity angiitis
 ;;^UTILITY(U,$J,358.3,3877,1,4,0)
 ;;=4^M31.0
 ;;^UTILITY(U,$J,358.3,3877,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,3878,0)
 ;;=M31.31^^33^278^22
 ;;^UTILITY(U,$J,358.3,3878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3878,1,3,0)
 ;;=3^Wegener's granulomatosis w/ renal involvement
 ;;^UTILITY(U,$J,358.3,3878,1,4,0)
 ;;=4^M31.31
 ;;^UTILITY(U,$J,358.3,3878,2)
 ;;=^5011745
 ;;^UTILITY(U,$J,358.3,3879,0)
 ;;=N28.89^^33^278^6
 ;;^UTILITY(U,$J,358.3,3879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3879,1,3,0)
 ;;=3^Kidney & Ureter Disorders,Oth Specified
 ;;^UTILITY(U,$J,358.3,3879,1,4,0)
 ;;=4^N28.89
 ;;^UTILITY(U,$J,358.3,3879,2)
 ;;=^88007
 ;;^UTILITY(U,$J,358.3,3880,0)
 ;;=E85.4^^33^278^11
 ;;^UTILITY(U,$J,358.3,3880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3880,1,3,0)
 ;;=3^Organ-limited amyloidosis
 ;;^UTILITY(U,$J,358.3,3880,1,4,0)
 ;;=4^E85.4
 ;;^UTILITY(U,$J,358.3,3880,2)
 ;;=^5003017
 ;;^UTILITY(U,$J,358.3,3881,0)
 ;;=M32.14^^33^278^2
 ;;^UTILITY(U,$J,358.3,3881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3881,1,3,0)
 ;;=3^Glomerular disease in systemic lupus erythematosus
 ;;^UTILITY(U,$J,358.3,3881,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,3881,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,3882,0)
 ;;=M32.15^^33^278^15
 ;;^UTILITY(U,$J,358.3,3882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3882,1,3,0)
 ;;=3^Tubulo-interstitial neuropathy in SLE
 ;;^UTILITY(U,$J,358.3,3882,1,4,0)
 ;;=4^M32.15
 ;;^UTILITY(U,$J,358.3,3882,2)
 ;;=^5011758
 ;;^UTILITY(U,$J,358.3,3883,0)
 ;;=M34.0^^33^278^13
 ;;^UTILITY(U,$J,358.3,3883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3883,1,3,0)
 ;;=3^Progressive systemic sclerosis
 ;;^UTILITY(U,$J,358.3,3883,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,3883,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,3884,0)
 ;;=M31.1^^33^278^14
 ;;^UTILITY(U,$J,358.3,3884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3884,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,3884,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,3884,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,3885,0)
 ;;=E85.81^^33^278^7
 ;;^UTILITY(U,$J,358.3,3885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3885,1,3,0)
 ;;=3^Light Chain (AL) Amyloidosis
 ;;^UTILITY(U,$J,358.3,3885,1,4,0)
 ;;=4^E85.81
 ;;^UTILITY(U,$J,358.3,3885,2)
 ;;=^5151302
 ;;^UTILITY(U,$J,358.3,3886,0)
 ;;=E85.82^^33^278^23
 ;;^UTILITY(U,$J,358.3,3886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3886,1,3,0)
 ;;=3^Wild-Type Transthyretin-Related (ATTR) Amyloidosis
 ;;^UTILITY(U,$J,358.3,3886,1,4,0)
 ;;=4^E85.82
 ;;^UTILITY(U,$J,358.3,3886,2)
 ;;=^5151303
 ;;^UTILITY(U,$J,358.3,3887,0)
 ;;=E85.89^^33^278^1
 ;;^UTILITY(U,$J,358.3,3887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3887,1,3,0)
 ;;=3^Amyloidosis,Other
 ;;^UTILITY(U,$J,358.3,3887,1,4,0)
 ;;=4^E85.89
 ;;^UTILITY(U,$J,358.3,3887,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,3888,0)
 ;;=Z87.442^^33^279^1
 ;;^UTILITY(U,$J,358.3,3888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3888,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,3888,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,3888,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,3889,0)
 ;;=N20.0^^33^279^2
 ;;^UTILITY(U,$J,358.3,3889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3889,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,3889,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,3889,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,3890,0)
 ;;=N20.1^^33^279^3
 ;;^UTILITY(U,$J,358.3,3890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3890,1,3,0)
 ;;=3^Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,3890,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,3890,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,3891,0)
 ;;=N20.2^^33^279^4
 ;;^UTILITY(U,$J,358.3,3891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3891,1,3,0)
 ;;=3^Calculus of Kidney w/ Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,3891,1,4,0)
 ;;=4^N20.2
 ;;^UTILITY(U,$J,358.3,3891,2)
 ;;=^5015609
 ;;^UTILITY(U,$J,358.3,3892,0)
 ;;=N20.9^^33^279^5
 ;;^UTILITY(U,$J,358.3,3892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3892,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,3892,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,3892,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,3893,0)
 ;;=E72.53^^33^279^6
 ;;^UTILITY(U,$J,358.3,3893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3893,1,3,0)
 ;;=3^Hyperoxaluria
 ;;^UTILITY(U,$J,358.3,3893,1,4,0)
 ;;=4^E72.53
 ;;^UTILITY(U,$J,358.3,3893,2)
 ;;=^60210
 ;;^UTILITY(U,$J,358.3,3894,0)
 ;;=R78.89^^33^280^1
 ;;^UTILITY(U,$J,358.3,3894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3894,1,3,0)
 ;;=3^Lithium Toxicity
 ;;^UTILITY(U,$J,358.3,3894,1,4,0)
 ;;=4^R78.89
 ;;^UTILITY(U,$J,358.3,3894,2)
 ;;=^5019588
 ;;^UTILITY(U,$J,358.3,3895,0)
 ;;=Z99.2^^33^281^3
 ;;^UTILITY(U,$J,358.3,3895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3895,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,3895,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,3895,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,3896,0)
 ;;=Z91.15^^33^281^6
 ;;^UTILITY(U,$J,358.3,3896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3896,1,3,0)
 ;;=3^Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,3896,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,3896,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,3897,0)
 ;;=Z49.31^^33^281^1
 ;;^UTILITY(U,$J,358.3,3897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3897,1,3,0)
 ;;=3^Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,3897,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,3897,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,3898,0)
 ;;=Z49.32^^33^281^2
 ;;^UTILITY(U,$J,358.3,3898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3898,1,3,0)
 ;;=3^Adequacy Testing for Peritoneal Dialysis
 ;;^UTILITY(U,$J,358.3,3898,1,4,0)
 ;;=4^Z49.32
 ;;^UTILITY(U,$J,358.3,3898,2)
 ;;=^5063059
 ;;^UTILITY(U,$J,358.3,3899,0)
 ;;=Z49.01^^33^281^4
 ;;^UTILITY(U,$J,358.3,3899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3899,1,3,0)
 ;;=3^Fit/Adjustment of Extracorporeal Dialysis Catheter
 ;;^UTILITY(U,$J,358.3,3899,1,4,0)
 ;;=4^Z49.01
 ;;^UTILITY(U,$J,358.3,3899,2)
 ;;=^5063056
 ;;^UTILITY(U,$J,358.3,3900,0)
 ;;=Z49.02^^33^281^5
 ;;^UTILITY(U,$J,358.3,3900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3900,1,3,0)
 ;;=3^Fit/Adjustment of Peritoneal Dialysis Catheter
 ;;^UTILITY(U,$J,358.3,3900,1,4,0)
 ;;=4^Z49.02
 ;;^UTILITY(U,$J,358.3,3900,2)
 ;;=^5063057
 ;;^UTILITY(U,$J,358.3,3901,0)
 ;;=Z91.5^^33^282^1
 ;;^UTILITY(U,$J,358.3,3901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3901,1,3,0)
 ;;=3^Personal Hx of Suicide Attempt(s)
 ;;^UTILITY(U,$J,358.3,3901,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,3901,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,3902,0)
 ;;=R45.851^^33^282^2
 ;;^UTILITY(U,$J,358.3,3902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3902,1,3,0)
 ;;=3^Suicideal Ideations
 ;;^UTILITY(U,$J,358.3,3902,1,4,0)
 ;;=4^R45.851
 ;;^UTILITY(U,$J,358.3,3902,2)
 ;;=^5019474
 ;;^UTILITY(U,$J,358.3,3903,0)
 ;;=T14.91XA^^33^282^3
 ;;^UTILITY(U,$J,358.3,3903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3903,1,3,0)
 ;;=3^Suicide Attempt,Initial Encntr
 ;;^UTILITY(U,$J,358.3,3903,1,4,0)
 ;;=4^T14.91XA
 ;;^UTILITY(U,$J,358.3,3903,2)
 ;;=^5151779
 ;;^UTILITY(U,$J,358.3,3904,0)
 ;;=T14.91XD^^33^282^4
 ;;^UTILITY(U,$J,358.3,3904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3904,1,3,0)
 ;;=3^Suicide Attempt,Subsequent Encntr
 ;;^UTILITY(U,$J,358.3,3904,1,4,0)
 ;;=4^T14.91XD
 ;;^UTILITY(U,$J,358.3,3904,2)
 ;;=^5151780
 ;;^UTILITY(U,$J,358.3,3905,0)
 ;;=T14.91XS^^33^282^5
 ;;^UTILITY(U,$J,358.3,3905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3905,1,3,0)
 ;;=3^Suicide Attempt,Sequela
 ;;^UTILITY(U,$J,358.3,3905,1,4,0)
 ;;=4^T14.91XS
 ;;^UTILITY(U,$J,358.3,3905,2)
 ;;=^5151781
 ;;^UTILITY(U,$J,358.3,3906,0)
 ;;=N17.1^^34^283^2
 ;;^UTILITY(U,$J,358.3,3906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3906,1,3,0)
 ;;=3^Acute kidney failure w/ acute cortical necrosis
 ;;^UTILITY(U,$J,358.3,3906,1,4,0)
 ;;=4^N17.1
 ;;^UTILITY(U,$J,358.3,3906,2)
 ;;=^5015599
 ;;^UTILITY(U,$J,358.3,3907,0)
 ;;=N17.2^^34^283^3
 ;;^UTILITY(U,$J,358.3,3907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3907,1,3,0)
 ;;=3^Acute kidney failure w/ medullary necrosis
 ;;^UTILITY(U,$J,358.3,3907,1,4,0)
 ;;=4^N17.2
 ;;^UTILITY(U,$J,358.3,3907,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,3908,0)
 ;;=N17.8^^34^283^1
 ;;^UTILITY(U,$J,358.3,3908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3908,1,3,0)
 ;;=3^Acute Kidney Failure NEC
 ;;^UTILITY(U,$J,358.3,3908,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,3908,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,3909,0)
 ;;=N17.9^^34^283^4
 ;;^UTILITY(U,$J,358.3,3909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3909,1,3,0)
 ;;=3^Acute kidney failure, unspecified
 ;;^UTILITY(U,$J,358.3,3909,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,3909,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,3910,0)
 ;;=I09.9^^34^284^24
 ;;^UTILITY(U,$J,358.3,3910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3910,1,3,0)
 ;;=3^Rheumatic heart disease, unspecified
 ;;^UTILITY(U,$J,358.3,3910,1,4,0)
 ;;=4^I09.9
 ;;^UTILITY(U,$J,358.3,3910,2)
 ;;=^5007061
 ;;^UTILITY(U,$J,358.3,3911,0)
 ;;=I10.^^34^284^15
 ;;^UTILITY(U,$J,358.3,3911,1,0)
 ;;=^358.31IA^4^2
